about
Expression profiling of the developing and mature Nrl-/- mouse retina: identification of retinal disease candidates and transcriptional regulatory targets of NrlMouse eye gene microarrays for investigating ocular development and disease.Gene expression profile of fibrovascular membranes from patients with proliferative diabetic retinopathy.Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease.Development and preclinical evaluation of a new viewing filter system to control reflection and enhance dye staining during vitrectomy.Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization.Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranesLack of lymphatics and lymph node-mediated immunity in choroidal neovascularization.Improved brilliant blue G staining of the internal limiting membrane with sharp cut filters of a novel viewing filter system.Spontaneous remission of acute zonal occult outer retinopathy: follow-up using adaptive optics scanning laser ophthalmoscopy.High-Resolution Imaging by Adaptive Optics Scanning Laser Ophthalmoscopy Reveals Two Morphologically Distinct Types of Retinal Hard Exudates.Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV.Gene Expression Analysis of the Irrigation Solution Samples Collected during Vitrectomy for Idiopathic Epiretinal Membrane.The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathyROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration.Chromovitrectomy and vital dyes.Periostin Promotes Scar Formation through the Interaction between Pericytes and Infiltrating Monocytes/Macrophages after Spinal Cord Injury.Applications of CRISPR/Cas9 in retinal degenerative diseasesRho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases.Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy.Imaging of Retinal Vascular Layers: Adaptive Optics Scanning Laser Ophthalmoscopy Versus Optical Coherence Tomography Angiography.Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders.Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal NeovascularizationInterleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy.Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization.Quantifying metamorphopsia with M-CHARTS in patients with idiopathic macular hole.Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathyInduction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation.Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy.Different roles played by periostin splice variants in retinal neovascularization.Diverse roles of macrophages in intraocular neovascular diseases: a review.Case of novel PITX2 gene mutation associated with Peters' anomaly and persistent hyperplastic primary vitreous.Periostin in vitreoretinal diseases.Optical Coherence Tomography Angiography Reveals Spatial Bias of Macular Capillary Dropout in Diabetic Retinopathy.Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa.INTERNAL LIMITING MEMBRANE PEELING-DEPENDENT RETINAL STRUCTURAL CHANGES AFTER VITRECTOMY IN RHEGMATOGENOUS RETINAL DETACHMENT.Quantitative analysis of vitreous and plasma concentrations of brilliant blue g after use as a surgical adjuvant in chromovitrectomy.
P50
Q28591943-69308E75-6C69-45DC-885B-374382DC71F9Q30815468-A6F10890-94B1-4F2D-9814-E0DE7E977068Q30888136-96B21994-EB3B-4D79-A2D1-509C8ACA6C6DQ33634500-DACCED8E-3469-4AF3-84AF-B61A331F3AE7Q33911009-8DE698F8-8128-4040-8675-F326CA03C598Q34262739-EA9CB25B-85DF-4FE8-BF7F-77AFD0C3C158Q34414482-2490A7EF-2BD5-4EDE-B805-8FDDAC19F659Q34548057-53869FB9-F49B-4015-99E0-1574CD055A13Q34571014-384A8A9E-0C44-44D9-A638-BD6B33A208B4Q34666369-0B233A45-6408-456C-8380-5970269F1C31Q34983372-E3086A30-7C11-4691-8B8F-AD8745B9CBD9Q35216682-88606CE9-4A91-40AD-A65D-2FEE458B501EQ36136724-13D66065-C656-4FF2-AEDB-DEEC3D95065FQ36144760-0F038B63-77AE-477B-BBD2-B0E570D994EEQ36162626-C6792148-C007-4520-92BE-19A3E7DD7148Q36906881-DB5DFEEC-1739-47F3-82F1-102E0A93AB50Q37570020-BB94CD2D-74DC-4B5C-9C96-987ECB09C697Q38246743-8912A685-A766-4D05-9162-BE706C1DD9BAQ39023852-B9EAEB00-90A3-400C-A551-F6F58F602C35Q39306038-3724B918-7BCB-450B-8E3A-A363AB485A73Q39361069-AE1CC521-3E3D-4706-A595-67BED87DD742Q41554390-DE3ED898-1345-4470-8E38-9399A09CF0EDQ41589502-DAF8657C-9D62-46D7-9EA0-071BAE7F9FC0Q41695212-CABC1FA9-137E-46C2-B479-1B6F1585B644Q41717727-B523F9BF-EE2C-4A71-8130-3FE9884143C1Q41819513-0900A9E6-C682-4F7D-9AED-5F482FB1FD54Q41906680-CBF588EF-703C-4794-9852-D72D48A51A55Q42040053-2745A4CE-6E88-4C18-8372-2CA818F4BD47Q42364446-7CA576A1-5F12-4AFA-BEEB-9B793EEC2089Q42364451-81ECC700-CF8B-4EB3-937D-5B078445B5E5Q44804461-91A02158-231D-4138-AA09-EF651C8AD986Q45791104-B9A96699-51B6-44EF-88E8-FB61D4AEAB62Q45859189-F2EBF077-9012-4CE3-AC5C-68FCA983897FQ47202861-6F9D0DA9-8C00-433C-A97C-2F3CE3DEEB55Q47746506-3AA90AD2-1B71-479F-BB9C-BB7B1B993C81Q47797906-D2F9A35D-7A6B-4B79-BFFD-C0A95D7614FAQ47917028-32AB6709-B5B8-40FD-A1D4-0627506ADBD5Q48351926-3C33BFBF-4C9A-4ED5-9F6D-0D72E56AD317Q50185192-95F72F30-18EE-45A0-AACC-070385D15112Q50235272-F9992656-24A2-4722-A962-104C2F136E26
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shigeo Yoshida
@ast
Shigeo Yoshida
@en
Shigeo Yoshida
@es
Shigeo Yoshida
@nl
type
label
Shigeo Yoshida
@ast
Shigeo Yoshida
@en
Shigeo Yoshida
@es
Shigeo Yoshida
@nl
prefLabel
Shigeo Yoshida
@ast
Shigeo Yoshida
@en
Shigeo Yoshida
@es
Shigeo Yoshida
@nl
P106
P1153
56446105700
P31
P496
0000-0003-1049-8909